Skip to content

Anesthetic occupational exposure during medical residency - impact on oxidative stress and toxicogenomic, biochemical and neuroendocrine assessments: longitudinal study

Anesthetic occupational exposure during medical residency - impact on oxidative stress and toxicogenomic, biochemical and neuroendocrine assessments: longitudinal study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-4vvkhz
Enrollment
Unknown
Registered
2017-12-01
Start date
2015-03-25
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1) Genotoxicity 2) Occupational Exposure 3) Diseases of the endocrine system 4) Immune system disorders

Interventions

Biomonitoring of the participants by means of venous blood collection. Experimental group: 23 resident physicians occupationally exposed to the residues of inhalational anesthetics, from the beginning

Sponsors

Departamento de Anestesiologia
Lead Sponsor
Faculade de Medina de Botucatu - UNESP
Collaborator

Eligibility

Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Start of medical residency in 2015 in anesthesiology areas; general surgery; orthopedics; neurosurgery; healthy volunteers; both genders; age between 18 and 35 years

Exclusion criteria

Exclusion criteria: Have done medical residence in the areas of interest of the study; Carrier malignancy; be more than 35 years of age

Design outcomes

Primary

MeasureTime frame
As expected, the potential increase in DNA damage detected by the comet assay, cytotoxicity assessed by flow cytometry, oxidative stress from protein and lipid oxidation markers by immunoassay (ELISA), and biochemical markers for dry and hormonal chemistry by chemiluminescence during the time of occupational exposure of study participants. The tests using all the mentioned markers are in progress and the sample size was calculated based on the MDA (lipid oxidation marker) evaluation, determining 23 individuals, with 95% test power.

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactAline Aun

Faculade de Medina de Botucatu - UNESP

aline.aun@hotmail.com5514996171409

Outcome results

None listed

Source: REBEC (via WHO ICTRP)